ARTICLE | Clinical News
DepoMed starts Phase II with Metformin
September 27, 2000 7:00 AM UTC
DMI started a Phase II trial to compare an extended release formulation of metformin with Bristol-Myers Squibb's marketed immediate release formulation, Glucophage, for the treatment of Type II diabet...